在使用基于LC-MS/MS的条纹性代谢学研究中,探索Gastrodia elata Blume在帕金森病中的潜在保护机制
Dongyan Guan1, Mengdi Wang2, Mijia Zhang2
1Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing, 100193, China; National Nanfan Research Institute (Sanya), Chinese Academy of Agricultural Sciences, Sanya, 572024, China; Institute of Processing & Design of Agro-products, Hainan Academy of Agricultural Science, Haikou, 571100, China.
Journal of ethnopharmacology
|June 22, 2025
概括
胃叶叶芽 (Gastrodia elata Blume,简称GEB) 提取物通过减少炎症和改善运动功能来治疗帕金森病 (PD) 是有前途的. 这项研究探讨了GEB对小鼠MPTP诱导的PD的保护作用,揭示了其对功能性食物开发的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 代谢学 代谢学 代谢学
背景情况:
- 胃叶 (Gastrodia elata Blume,简称GEB) 是一种传统的中医药,具有很长的使用历史.
- 它的茎是天玛古阴的关键组成部分,用于神经疾病.
- 之前没有研究研究GEB对帕金森病 (PD) 中条纹代谢物的影响.
研究的目的:
- 在小鼠模型中评估GEB对MPTP诱导的帕金森病 (PD) 的保护作用.
- 调查GEB治疗作用的潜在机制,包括其对代谢物的影响.
主要方法:
- 在MPTP诱导之前,小鼠被用GEB (100-300 mg/kg) 治疗.
- 通过步态分析和杆测试来评估运动行为.
- 分析了炎症标志物 (IL-1β,IL-6,TNF-α),黑色物质损伤和条状细胞代谢.
主要成果:
- 在PD小鼠中,GEB改善了运动功能,步态参数,并减少了爬时间.
- 在状体中,GEB显著抑制了IL-1β,IL-6和TNF-α的升高水平.
- GEB改善了黑色物质的神经退行,并调节了关键的代谢途径.
结论:
- GEB 提取物对MPTP诱导的PD具有神经保护作用.
- 通过减少炎症和神经元损伤,GEB可以减轻PD的症状.
- GEB调节脂质代谢,可能是PD功能性食物的候选者.
相关概念视频
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722


